Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research (original) (raw)

References

  1. Cohen, M. H. et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukaemia. Clin. Cancer Res. 8, 935–942 (2002).
    CAS PubMed Google Scholar
  2. Siena, S., Sartore-Bianchi. A., di Nicolantonio, F., Balfour, J. & Bardelli, A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J. Natl Cancer Inst. 101, 1308–1324 (2009).
    Article CAS Google Scholar
  3. Lemieux, J., Provencher, L., Latreilly, J., Rayson, D. & Wang, B. The role of neoadjuvant Her2-targeted therapies in HER2-overexpressing breast cancers. Curr. Oncol. 16, 48–57 (2009).
    Article CAS Google Scholar
  4. Tan, D. S. W. et al. Biomarker-driven early clinical trials in oncology. Cancer J. 15, 406–420 (2009).
    Article CAS Google Scholar
  5. Bonavida, B. Preface. Antibody therapies for cancer. Oncogene 26, 3592–3593 (2007).
    Article CAS Google Scholar
  6. Taube, S. E. et al. A perspective on challenges and issues in biomarker development and drug and biomarker co development. J. Natl Cancer Inst. 101, 1453–1463 (2009).
    Article Google Scholar
  7. Caporaso, N. E. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol. Biomarkers Prev. 11, 1544–1549 (2002).
    PubMed Google Scholar
  8. Burton, P. R. et al. Size matters: just how big is BIG? Quantifying realistic sample size requirements for human geneome epidemiology. Int. J. Epidemiol. 38, 263–273 (2009).
    Article Google Scholar
  9. Bevilacqua, G. et al. The role of the pathologist in tissue banking: european consensus expert group report. Virchows Arch. 456, 449–542010.
  10. Riegman, P. H. J., de Jong, B. W. D. & Llombart-Bosch, A. The organization of European cancer institute pathobiology working group and its support for European biobanking infrastructure for translational cancer research. Cancer Epidemiol. Biomarkers Prev. 19, 923–926 (2010).
    Article Google Scholar
  11. Buetow, K. H. An infrastructure for interconnecting research institutions. Drug Disc. Today 14, 605–610 (2009).
    Article Google Scholar
  12. Goosner, M. National Comprehensive Cancer Networks (NCCN) — big data basis outcomes research begins to yield results. J. Natl. Cancer Inst. 102, 215–217 (2010).
    Article Google Scholar
  13. Cambon-Thomsen, A. Accessing the impact of biobanks. Nature Genet. 34, 25–26 (2003).
    Article Google Scholar
  14. International Society of Biological and Environmental Repositories. Best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Cell Preserv. Technol. 6, 3–56 (2008).
  15. The German Ethics Council Biobanks for Research, Opinion. Deutscher Ethikrat [online] (2004).
  16. Sheikh, A. A. Genetic research and human biological samples: some legal and ethical considerations. Med. Law 23, 897–912 (2004).
    PubMed Google Scholar
  17. Elger, B. S. & Caplan, A. L. Consent and anonymization in research involving biobanks. EMBO J. 7, 661–666 (2006).
    Article CAS Google Scholar
  18. Annas, G. Rules for research on human genetic variation – lessons from Iceland. N. Engl. J. Med. 342, 1830–1833 (2000).
    Article CAS Google Scholar
  19. Chadwick, R. & Berg, K. Solidarity and equity: new ethical frameworks for genetic databases. Nature Rev. Genet. 2, 318–321 (2001).
    Article CAS Google Scholar
  20. O'Neill, O. Informed consent and genetic information. Stud. Hist. Philos. Biol. Biomed. Sci. 32, 689–704 (2001).
    Article Google Scholar
  21. Ravitsky, V., Fiester, A. & Caplan, A. (eds) The Penn Center Guide to Bioethics (Springer Publishing, New York, USA, 2009).
    Google Scholar
  22. Hakimian, R. & Korn, D. Ownership and use of tissue specimens for reseach. JAMA 292, 2500–2505 (2004).
    Article CAS Google Scholar
  23. Wolf, L. E., Bouley, T. A. & McCulloch, C. E. Genetic research and stored biological materials: ethics and practice. IRB 32, 7–18 (2010).
    PubMed PubMed Central Google Scholar
  24. Council of Europe Draft explanatory memorandum to the draft recommendation on research on biological materials of human origin, Strasbourg. Council of Europe Steeting committee on Bioethics [online] (2006).
  25. Campbell, A. V. The ethical challenges for genetic databases: safeguarding altruism and trust. Kings Law J. 18, 373–382 (2007).
    Google Scholar
  26. Shickle, D. The consent problem with DNA biobanks. Stud. Hist. Philos. Biol. Biomed. Sci. 37, 503–519 (2006).
    Article Google Scholar
  27. Helgesson, G., Dillner, J., Carlson, J., Bartram, C. R. & Hansson, M. G. Ethical framework for previously collected biobank samples. Nature Biotechnol. 25, 973–976 (2007).
    Article CAS Google Scholar
  28. Slater, B. & Jones, M. Biobanks and bioethics: politics of legitimation. J. Eur. Pub. Pol. 12, 710–732 (2005).
    Article Google Scholar
  29. Putnina, A. Exploring the articulation of agency: Population genome project in Latvia. International Summer Academy on Technology Studies [online] (2002).
  30. Gertz, R. Withdrawing from participating in a biobank — a comparative study. Eur. J. Health Law 15, 381–389 (2008).
    Article Google Scholar
  31. Hansson, M. G. et al. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol. 3, 266–269 (2006).
    Article Google Scholar

Download references